MURINE MACROPHAGES LACK EXPRESSION OF THE CR-2-145 (CR-2) AND CR-2-190 (CR-1) GENE-PRODUCTS

被引:24
作者
MARTIN, BK [1 ]
WEIS, JH [1 ]
机构
[1] UNIV UTAH,SCH MED,DEPT PATHOL,DIV CELL BIOL & IMMUNOL,SALT LAKE CITY,UT 84132
关键词
COMPLEMENT; RECEPTOR; MOUSE; MACROPHAGES;
D O I
10.1002/eji.1830231146
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine macrophages have been described as possessing complement receptors for C3b and iC3b. These binding activities have been assumed to be due to the presence of the CR1 and CR3 proteins, respectively. The mouse Cr2 gene produces two distinct gene products of approximately 190 000 relative molecular mass (M(r)) (Cr2-190) and 145 000 M(r) (Cr2-145). Because of the similarity in size to human complement receptors, the Cr2-190 protein has been dubbed murine CR1 while the murine Cr2-145 product has been termed murine CR2. In order to define the complement receptor genes expressed by murine macrophages, we investigated the expression patterns of Cr2-190, Cr2-145 and another mouse complement receptor, Crry, in three different mouse macrophage populations: bane marrow-derived macrophages, thioglycollate-elicited peritoneal macrophages and the macrophage cell line, J774. Neither of the Cr2 gene transcripts encoding the Cr2-145 and Cr2-190 proteins could be detected in these populations by RT-RPCR analysis although Crry transcripts were evident. Cr2-145 and Cr2s-190 proteins could not be detected on the surface of thioglycollate-elicited macrophages using a monoclonal antibody that recognizes both proteins. Thus, contrary to previously published data, murine macrophages do not possess the Cr2 gene products.
引用
收藏
页码:3037 / 3042
页数:6
相关论文
共 33 条
[1]   ANTI-MAC-1 SELECTIVELY INHIBITS THE MOUSE AND HUMAN TYPE 3 COMPLEMENT RECEPTOR [J].
BELLER, DI ;
SPRINGER, TA ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) :1000-1009
[2]   STUDIES OF MACROPHAGE COMPLEMENT RECEPTOR - ALTERATION OF RECEPTOR FUNCTION UPON MACROPHAGE ACTIVATION [J].
BIANCO, C ;
GRIFFIN, FM ;
SILVERSTEIN, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (06) :1278-1290
[3]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[4]  
CHRISTENSEN SM, 1992, J IMMUNOL, V148, P3610
[5]   IDENTIFICATION OF MURINE COMPLEMENT RECEPTOR TYPE-2 [J].
FINGEROTH, JD ;
BENEDICT, MA ;
LEVY, DN ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :242-246
[6]  
FINGEROTH JD, 1990, J IMMUNOL, V144, P3458
[7]  
HOLGUIN MH, 1990, J IMMUNOL, V145, P1776
[8]  
KINOSHITA T, 1988, J IMMUNOL, V140, P3066
[9]  
KINOSHITA T, 1985, J IMMUNOL, V134, P2564
[10]  
KINOSHITA T, 1991, DENDRITIC CELLS LYMP, P53